Guillermo Montalban-Bravo Selected Research

Guillermo Montalban-Bravo Research Topics

Disease

24	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2024 - 04/2018
22	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 03/2024 - 05/2017
14	Neoplasms (Cancer) 03/2024 - 01/2017
11	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 03/2024 - 01/2017
5	Leukemia 12/2022 - 01/2021
4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2024 - 10/2017
3	Disease Progression 05/2024 - 01/2022
3	Anemia 01/2023 - 01/2018
3	Infections 01/2023 - 01/2022
3	Philadelphia Chromosome 01/2023 - 01/2021
2	Thrombocytopenia (Thrombopenia) 01/2023 - 01/2022
2	Blast Crisis (Blast Phase) 01/2023 - 10/2021
2	Chromosome Aberrations (Chromosome Abnormalities) 01/2023 - 01/2022
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2021 - 01/2021
1	Second Primary Neoplasms (Neoplasms, Second) 03/2024
1	Multiple Myeloma 02/2023
1	Hypertension (High Blood Pressure) 01/2023
1	Tremor (Tremors) 01/2023
1	Thrombosis (Thrombus) 01/2023
1	Coronary Stenosis (Coronary Artery Stenosis) 01/2023
1	Pain (Aches) 01/2023
1	Invasive Fungal Infections 10/2022
1	Leukocytosis (Pleocytosis) 01/2022
1	Fever of Unknown Origin 01/2022
1	BCR-ABL Negative Atypical Chronic Myeloid Leukemia (Leukemia, Myeloid, Philadelphia Negative) 01/2021
1	B-Cell Leukemia (Leukemia, B Cell) 01/2019

Drug/Important Bio-Agent (IBA)

19	venetoclaxIBA 03/2024 - 01/2021
7	Azacitidine (5 Azacytidine)FDA Link 01/2023 - 01/2017
4	Decitabine FDA Link 02/2024 - 01/2017
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2017
2	DNA (Deoxyribonucleic Acid)IBA 02/2023 - 01/2019
2	blinatumomabIBA 01/2023 - 01/2021
2	Cladribine FDA LinkGeneric 01/2023 - 11/2022
2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2023 - 11/2022
2	EnzymesIBA 01/2023 - 01/2023
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2023 - 01/2022
2	Enhancer of Zeste Homolog 2 ProteinIBA 01/2022 - 01/2019
2	Lenalidomide (CC 5013)FDA Link 01/2019 - 01/2018
1	cedazuridineIBA 02/2024
1	CPX-351IBA 11/2023
1	Hydroxyurea (Hydrea)FDA LinkGeneric 01/2023
1	Lipase (Acid Lipase)FDA Link 01/2023
1	Alanine Transaminase (SGPT)IBA 01/2023
1	Amylases FDA Link 01/2023
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2023
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2023
1	ponatinibIBA 01/2023
1	pevonedistatIBA 01/2023
1	enasidenibIBA 01/2023
1	DS-5272IBA 12/2022
1	RNA (Ribonucleic Acid)IBA 12/2022
1	TriazolesIBA 10/2022
1	NF-kappa B (NF-kB)IBA 01/2022
1	CreatinineIBA 01/2022
1	trametinibIBA 01/2022
1	Programmed Cell Death 1 ReceptorIBA 11/2021
1	pembrolizumabIBA 11/2021
1	LigandsIBA 11/2021
1	Codon (Codons)IBA 10/2021
1	Inotuzumab OzogamicinIBA 01/2021
1	Interferon Type IIBA 01/2021
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	Core Binding Factors (Core-Binding Factor)IBA 01/2021
1	Cell-Free Nucleic AcidsIBA 01/2020
1	RNA Helicases (RNA Helicase)IBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	NucleophosminIBA 01/2019
1	MethyltransferasesIBA 01/2019
1	Janus Kinase 2IBA 01/2019
1	HomoharringtonineIBA 01/2019
1	DioxygenasesIBA 01/2019
1	Amino Acids FDA Link 04/2018
1	alpha-hydroxyglutarateIBA 04/2018
1	SB939 compoundIBA 05/2017

Therapy/Procedure

31	Therapeutics 03/2024 - 05/2017
11	Drug Therapy (Chemotherapy) 05/2024 - 01/2019
2	Immunotherapy 01/2022 - 01/2020
1	Remission Induction 10/2022
1	Salvage Therapy 01/2021